I don’t think there will be a ‘second wave’. Only my personal opinion but I think if it was gonna happen it would already have happened. There will be spikes in certain areas of course.
It has been ruled out as a treatment for Covid 19 This is just notice of a future clinical study to see if it prevents the infection The Mahidol Oxford Tropical Medicine Research Unit (MORU) has enrolled 40,000 frontline workers in Europe, Africa, Asia and South America who will receive either chloroquine, hydroxychloroquine or a placebo. It's hoped the double-blind, randomised study will reveal if hydroxychloroquine can prevent the virus from developing or greatly reduce chances of hospitalisation if taken soonafter infection. One of the lead researchers of the 'Copcov' trial, Dr Will Schilling, said the question on whether hydroxychloroquine "works or not in prevention or very early treatment… remains unanswered". This is based on the "feeling" that there are not as many SARS2 infections in Africa as the models have predicted. Is it because the numbers are not being reported/tested/known....or is there something in the African life style that uis cutting the infection rate...e.g. taking hydroxychloroquine to prevent malaria
3 counties here been locked down for 2 weeks....Laois, offaly and kildare.....due to a spike in cases....locals not happy but probably right thing to do.... There's a lot of people in tramore on holiday and likely to include people from those counties so keeping away from the touristy end of town.... Stay safe all...
Yeah we should have prioritised saving lives over good PR for the government in hindsight. Was always a tough call.
Well there's a thing. They successfully protected the NHS, though - by making people too scared to use it.
AstraZeneca to be exempt from coronavirus vaccine liability claims in most countries Ludwig Burger, Pushkala Aripaka 3 Min Read (Reuters) - AstraZeneca has been granted protection from future product liability claims related to its COVID-19 vaccine hopeful by most of the countries with which it has struck supply agreements, a senior executive told Reuters. FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo With 25 companies testing their vaccine candidates on humans and getting ready to immunise hundred millions of people once the products are shown to work, the question of who pays for any claims for damages in case of side effects has been a tricky point in supply negotiations. “This is a unique situation where we as a company simply cannot take the risk if in ... four years the vaccine is showing side effects,” Ruud Dobber, a member of Astra’s senior executive team, told Reuters. “In the contracts we have in place, we are asking for indemnification. For most countries it is acceptable to take that risk on their shoulders because it is in their national interest,” he said, adding that Astra and regulators were making safety and tolerability a top priority. Dobber would not name the countries. EU officials told Reuters this week product liability was among contentious points in European efforts to secure supply deals for potential COVID-19 vaccines from Pfizer, Sanofi and Johnson & Johnson. The United States, however, already has a law to exclude tort claims from products that help control a public-health crises in the form of the 2005 Public Readiness and Emergency Preparedness, or PREP Act. AstraZeneca, Britain’s second-largest drugmaker, has pledged to supply a total of more than 2 billion doses at no profit in agreements with the United States, Britain and European countries, among other nations and organisations. Astra’s deals differ from most rivals because it has secured government backing for production and development efforts, while competitors such as GlaxoSmithKline are looking to negotiate a price for a finished product, contingent on approval. To back its claim to forgo profits from the $1.2 billion collaboration in the United States, Astra has even granted the government access to financial accounts related to the venture, according to Dobber. “There are very clear milestones before they are going to pay. Because we made the promise to manufacture the vaccine at no profit, auditors of the U.S. administration will get free access to our accounting books,” he said.
Welcome back civic 19 Oh how we have missed you Auckland closed for a minimum of three days From 12 mid day tomorrow
They tell me Covid in Australia is like the Spice Girls......... everyone is working really hard but Victoria is letting the side down!!!!!
Anyone a Covid "long-hauler"? Seems more and more people are suffering long after the initial symptoms have gone away my missus being one of them Coronavirus: Thousands say debilitating symptoms last 'for weeks' Extreme fatigue, nausea, chest tightness, severe headaches, "brain fog" and limb pains are among the recurring symptoms described by some sufferers of Covid-19 for weeks - and even months - after their diagnosis. They call themselves "long-haulers" and their symptoms persist long after the 14-day period that's officially said to be the average length of the illness. There are calls for both health professionals and employers to recognise that some people will take a lot longer than two weeks to recover. "It's the weirdest thing I've ever experienced," Helen Calder, from Liverpool, told BBC health correspondent Dominic Hughes. Nearly four months after she and her family caught the virus, and after needing hospital treatment twice, she still experiences a relapse roughly every two weeks where she is hit by debilitating fatigue, nausea, headaches and limb pain. Her doctors have diagnosed post viral fatigue and she says any small over-exertion while she is feeling well can set her back for days at a time. https://www.bbc.com/news/health-53269391
Interesting watching the news yesterday regarding children/going back to school and infections.All charts and data showed that there is not a problem or been a problem.